These mechanisms involve a new investigator and a mentor/institution where the transition from student to independent investigator can be made, providing an invaluable experience for those transitioning into independent careers.
Small business grants (SBIRs, STTRs) are also represented in the portfolio and represent short-term investments into technologies and devices that may develop into vector control strategies. This mechanism encourages small businesses to become involved in research on novel mechanisms to better control and/or prevent vector-borne diseases.
The Vector Biology portfolio is well rounded in terms of the mechanisms represented and the type of research being supported, ranging from basic to translational. Figure 3-1 demonstrates different funding mechanisms available during these research phases.
Numerous projects headed by U.S. investigators contain foreign components. Some DMID initiatives, such as the International Research in Infectious Diseases (IRID) Program, and the Tropical Medicine Research Centers (TMRCs) are designed for investigators in foreign institutions. This is very important to the program as many vector-borne diseases occur in tropical and subtropical areas of the world and not in the United States. Foreign investigators are encouraged to take advantage of these initiatives whenever possible to fund their research projects.